EICHOR
● Active Not Recruiting
Prospective, Multi-Center, Observational, Whole Blood Specimen Collection Study in Participants With Rheumatoid Arthritis With Inadequate Response or Intolerance to a DMARD Starting a New bDMARD or tsDMARD Treatment +/- csDMARD
Condition: Rheumatoid Arthritis · Sponsor: Aqtual, Inc.
About this study
The primary goal of this study is to assess a cfDNA-based blood test using genetic, transcriptomic and/or epigenetic information to help doctors predict the best treatment options for rheumatoid arthritis (RA) patients with inadequate response or intolerance to previous therapies.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (42)
| Arizona Arthritis & Rheumatology Research | Phoenix, Arizona, United States | — |
| Medvin Clinical Research - Apple Valley | Apple Valley, California, United States | — |
| Medvin Clinical Research - Covina | Covina, California, United States | — |
| Medvin Clinical Research - Riverside | Riverside, California, United States | — |
| Medvin Clinical Research - Tujunga | Tujunga, California, United States | — |
| Medvin Clinical Research - Whittier | Whittier, California, United States | — |
| AARDS Research, Inc | Aventura, Florida, United States | — |
| Highlands Advanced Rheumatology and Arthritis Center (HARAC) | Avon Park, Florida, United States | — |
| Bay Area Rheumatology | Clearwater, Florida, United States | — |
| Believe Clinical Trials | Coral Springs, Florida, United States | — |
| GNP Research | Hollywood, Florida, United States | — |
| Life Clinical Trials | Margate, Florida, United States | — |
+ 30 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05936970